Recent insights into atopic dermatitis and implications for management of infectious complications.
暂无分享,去创建一个
[1] B. Moza,et al. Neutralization of multiple staphylococcal superantigens by a single-chain protein consisting of affinity-matured, variable domain repeats. , 2008, The Journal of infectious diseases.
[2] D. Leung. Our evolving understanding of the functional role of filaggrin in atopic dermatitis. , 2009, The Journal of allergy and clinical immunology.
[3] D. Leung,et al. Smallpox vaccination: Risk considerations for patients with atopic dermatitis. , 2002, The Journal of allergy and clinical immunology.
[4] H. Sampson,et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. , 1993, The Journal of clinical investigation.
[5] J. Carucci,et al. Low Expression of the IL-23/Th17 Pathway in Atopic Dermatitis Compared to Psoriasis1 , 2008, The Journal of Immunology.
[6] C. Saha,et al. Infected atopic dermatitis lesions contain pharmacologic amounts of lipoteichoic acid. , 2010, The Journal of allergy and clinical immunology.
[7] T. Bieber,et al. Reduction of relapses of atopic dermatitis with methylprednisolone aceponate cream twice weekly in addition to maintenance treatment with emollient: a multicentre, randomized, double‐blind, controlled study , 2008, The British journal of dermatology.
[8] S. Foster,et al. Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage. , 2006, The Journal of infectious diseases.
[9] T. Beaty,et al. Filaggrin mutations that confer risk of atopic dermatitis confer greater risk for eczema herpeticum. , 2009, The Journal of allergy and clinical immunology.
[10] T. Zuberbier,et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. , 2006, The Journal of allergy and clinical immunology.
[11] L. Skov,et al. Application of Staphylococcal enterotoxin B on normal and atopic skin induces up-regulation of T cells by a superantigen-mediated mechanism. , 2000, The Journal of allergy and clinical immunology.
[12] C. Salgado,et al. Community-acquired methicillin-resistant Staphylococcus aureus. , 2004, JAMA.
[13] M. Pembrey,et al. The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. , 2008, The Journal of allergy and clinical immunology.
[14] P. Savage,et al. Ceragenins: a class of antiviral compounds to treat orthopox infections. , 2009, The Journal of investigative dermatology.
[15] R. Dolin,et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus , 2004 .
[16] H. Williams,et al. Interventions to reduce Staphylococcus aureus in the management of atopic eczema. , 2008, The Cochrane database of systematic reviews.
[17] J. Ring,et al. IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response. , 2009, The Journal of allergy and clinical immunology.
[18] Gina Pugliese,et al. Nasal Carriage as a Source of Staphylococcus aureus Bacteremia , 2001, Infection Control & Hospital Epidemiology.
[19] M. Boguniewicz,et al. 10. Atopic dermatitis. , 2006, The Journal of allergy and clinical immunology.
[20] S. Holland,et al. The new england journal of medicine Combined Immunodeficiency Associated with DOCK 8 Mutations , 2009 .
[21] M. Boguniewicz,et al. Fibronectin and fibrinogen contribute to the enhanced binding of Staphylococcus aureus to atopic skin. , 2001, The Journal of allergy and clinical immunology.
[22] A. Irvine,et al. Filaggrin in atopic dermatitis. , 2009, The Journal of allergy and clinical immunology.
[23] S. Ständer,et al. Correlation of IL-31 serum levels with severity of atopic dermatitis. , 2008, The Journal of allergy and clinical immunology.
[24] H. Williams,et al. Global variations in prevalence of eczema symptoms in children from ISAAC Phase Three. , 2009, The Journal of allergy and clinical immunology.
[25] K. Barnes,et al. Cytokine modulation of atopic dermatitis filaggrin skin expression. , 2007, The Journal of allergy and clinical immunology.
[26] H. Cordell,et al. Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. , 2009, The Journal of allergy and clinical immunology.
[27] M. D. de Bruin‐Weller,et al. Cyclosporin A reduces CD4(+)CD25(+) regulatory T-cell numbers in patients with atopic dermatitis. , 2009, The Journal of allergy and clinical immunology.
[28] C. Deming,et al. Topographical and Temporal Diversity of the Human Skin Microbiome , 2009, Science.
[29] A. Rademaker,et al. Treatment of Staphylococcus aureus Colonization in Atopic Dermatitis Decreases Disease Severity , 2009, Pediatrics.
[30] C. W. Carspecken,et al. Defective killing of Staphylococcus aureus in atopic dermatitis is associated with reduced mobilization of human beta-defensin-3. , 2008, The Journal of allergy and clinical immunology.
[31] T. Bieber,et al. Proactive therapy of atopic dermatitis – an emerging concept , 2009, Allergy.
[32] M. Weichenthal,et al. Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis. , 2009, The Journal of allergy and clinical immunology.
[33] L. Ou,et al. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. , 2004, The Journal of allergy and clinical immunology.
[34] Donald Y M Leung,et al. Amendment history : Erratum ( April 2004 ) New insights into atopic dermatitis , 2018 .
[35] W. Cookson,et al. The genetics of atopic dermatitis. , 2006, The Journal of allergy and clinical immunology.
[36] R. Gallo,et al. Administration of oral vitamin D induces cathelicidin production in atopic individuals. , 2008, The Journal of allergy and clinical immunology.
[37] C. Naspitz,et al. The allergic sensitization in infants with atopic eczema from different countries , 2009, Allergy.
[38] A. Stolfi,et al. Efficacy of probiotics in the treatment of pediatric atopic dermatitis: a meta-analysis of randomized controlled trials. , 2008, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[39] G. Plewig,et al. Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases. , 2003, Journal of the American Academy of Dermatology.
[40] N. Novak,et al. Pulsed-Field Gel Electrophoresis of Staphylococcus aureus Isolates from Atopic Patients Revealing Presence of Similar Strains in Isolates from Children and Their Parents , 2007, Journal of Clinical Microbiology.
[41] P. Elias,et al. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. , 2008, The Journal of allergy and clinical immunology.
[42] L. Bielory,et al. Meta-analysis of clinical trials of probiotics for prevention and treatment of pediatric atopic dermatitis. , 2008, The Journal of allergy and clinical immunology.
[43] G. Stingl,et al. Atopic dermatitis: therapeutic concepts evolving from new pathophysiologic insights. , 2008, The Journal of allergy and clinical immunology.
[44] C. Camargo,et al. Randomized controlled trial of vitamin D supplementation for winter‐related atopic dermatitis in Boston: a pilot study , 2008, The British journal of dermatology.
[45] A. Wollenberg,et al. Viral infections in atopic dermatitis: pathogenic aspects and clinical management. , 2003, The Journal of allergy and clinical immunology.
[46] P. Beattie,et al. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases , 2006, The British journal of dermatology.
[47] M. Flaig,et al. Cathelicidin deficiency predisposes to eczema herpeticum. , 2006, The Journal of allergy and clinical immunology.
[48] K. Barnes,et al. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. , 2009, The Journal of allergy and clinical immunology.
[49] R. Kirsner,et al. Intermittent therapy for flare prevention and long-term disease control in stabilized atopic dermatitis: a randomized comparison of 3-times-weekly applications of tacrolimus ointment versus vehicle. , 2008, Journal of the American Academy of Dermatology.
[50] H Stammer,et al. Nasal Carriage as a Source of Staphylococcus aureus Bacteremia , 2001 .
[51] Q. Hamid,et al. Polarized in vivo expression of IL-11 and IL-17 between acute and chronic skin lesions. , 2003, The Journal of allergy and clinical immunology.
[52] B. Neumeister,et al. Role of teichoic acids in Staphylococcus aureus nasal colonization, a major risk factor in nosocomial infections , 2004, Nature Medicine.
[53] J. Redzic,et al. Th2 cytokines act on S100/A11 to downregulate keratinocyte differentiation. , 2008, The Journal of investigative dermatology.
[54] N. Klopp,et al. Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. , 2006, The Journal of allergy and clinical immunology.
[55] R. Geha,et al. Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge , 2007, Proceedings of the National Academy of Sciences.
[56] P. Savage,et al. Antibacterial properties of cationic steroid antibiotics. , 2002, FEMS microbiology letters.
[57] R. Kirsner,et al. Three Times Weekly Tacrolimus Ointment Reduces Relapse in Stabilized Atopic Dermatitis: A New Paradigm for Use , 2008, Pediatrics.
[58] J. Ring,et al. Efficacy and functionality of silver‐coated textiles in patients with atopic eczema , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.
[59] S. Holland,et al. Combined immunodeficiency associated with DOCK8 mutations. , 2009, The New England journal of medicine.
[60] E. Oren,et al. Vitamin D and atopic disorders in an obese population screened for vitamin D deficiency. , 2008, The Journal of allergy and clinical immunology.
[61] James F. Jones,et al. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. , 2006, Immunity.
[62] C. Palmer,et al. Filaggrin variants confer susceptibility to asthma. , 2008, The Journal of allergy and clinical immunology.
[63] S. Jolles. A review of high‐dose intravenous immunoglobulin treatment for atopic dermatitis , 2002, Clinical and experimental dermatology.
[64] H. R. Anderson,et al. Is eczema really on the increase worldwide? , 2008, The Journal of allergy and clinical immunology.
[65] S. Weber,et al. Severe eczema vaccinatum in a household contact of a smallpox vaccinee. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[66] A. Heinzmann,et al. Randomized, Double-Blind, Placebo-Controlled Trial of Probiotics for Primary Prevention: No Clinical Effects of Lactobacillus GG Supplementation , 2008, Pediatrics.
[67] B. Thiers. Serum IgE Autoantibodies Target Keratinocytes in Patients with Atopic Dermatitis , 2009 .
[68] James F. Jones,et al. Selective Killing of Vaccinia Virus by LL-37: Implications for Eczema Vaccinatum1 , 2004, The Journal of Immunology.
[69] U. Wahn,et al. Prevalence and role of serum IgE antibodies to the Staphylococcus aureus-derived superantigens SEA and SEB in children with atopic dermatitis. , 1999, The Journal of allergy and clinical immunology.
[70] Q. Hamid,et al. Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. , 1994, The Journal of clinical investigation.
[71] M. Boguniewicz,et al. Effects of cefuroxime axetil on Staphylococcus aureus colonization and superantigen production in atopic dermatitis. , 2001, The Journal of allergy and clinical immunology.
[72] P. Savage,et al. Synthesis and characterization of peptide-cationic steroid antibiotic conjugates. , 2004, Organic letters.
[73] T. Bieber,et al. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment , 2008, Allergy.
[74] M. Otto. Targeted Immunotherapy for Staphylococcal Infections , 2012, BioDrugs.
[75] Chien-Chang Lee,et al. Staphylococcus colonization in atopic dermatitis treated with fluticasone or tacrolimus with or without antibiotics. , 2007, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.
[76] Donald Y M Leung,et al. A multidisciplinary approach to evaluation and treatment of atopic dermatitis. , 2008, Seminars in cutaneous medicine and surgery.
[77] Zhou-Feng Chen,et al. Cellular Basis of Itch Sensation , 2009, Science.
[78] I I Lelis,et al. [Atopic dermatitis]. , 1980, Vestnik dermatologii i venerologii.
[79] A. Liu,et al. Severe atopic dermatitis is associated with a high burden of environmental Staphylococcus aureus , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[80] J. Istvan,et al. The prevalence of atopic dermatitis in Oregon schoolchildren. , 2000, Journal of the American Academy of Dermatology.
[81] R. Geha,et al. Filaggrin-deficient mice exhibit TH17-dominated skin inflammation and permissiveness to epicutaneous sensitization with protein antigen. , 2009, The Journal of allergy and clinical immunology.
[82] L. Beck,et al. Atopic dermatitis: a disease caused by innate immune defects? , 2009, The Journal of investigative dermatology.
[83] Tomas Ganz,et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. , 2002, The New England journal of medicine.
[84] T. Bieber,et al. Risk factors of atopic dermatitis patients for eczema herpeticum. , 2007, The Journal of investigative dermatology.
[85] Asher,et al. The International Study of Asthma and Allergies in Childhood (ISAAC) , 1998, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.
[86] A. Mejias,et al. Management and outcome of children with skin and soft tissue abscesses caused by community-acquired methicillin-resistant Staphylococcus aureus , 2004, The Pediatric infectious disease journal.
[87] D. Margolis,et al. The prevalence of atopic triad in children with physician-confirmed atopic dermatitis. , 2008, Journal of the American Academy of Dermatology.
[88] M. Boguniewicz,et al. Severe refractory atopic dermatitis in adults is highly atopic. , 2007, The Journal of allergy and clinical immunology.
[89] S. Walker,et al. Intravenous immunoglobulin contains specific antibodies inhibitory to activation of T cells by staphylococcal toxin superantigens [see comment]. , 1993, The Journal of clinical investigation.
[90] M. Steinhoff,et al. IL-31: a new link between T cells and pruritus in atopic skin inflammation. , 2006, The Journal of allergy and clinical immunology.
[91] L. Ou,et al. Staphylococcal enterotoxin B inhibits regulatory T cells by inducing glucocorticoid-induced TNF receptor-related protein ligand on monocytes. , 2006, The Journal of allergy and clinical immunology.
[92] M. Boguniewicz,et al. Loricrin and Involucrin Expression is Down-Regulated by Th2 Cytokines through STAT-6 , 2008 .
[93] M. Kopp,et al. Probiotics cannot be generally recommended for primary prevention of atopic dermatitis. , 2009, The Journal of allergy and clinical immunology.
[94] P. Schlievert,et al. Secreted virulence factor comparison between methicillin-resistant and methicillin-sensitive Staphylococcus aureus, and its relevance to atopic dermatitis. , 2010, The Journal of allergy and clinical immunology.
[95] A. Paller,et al. A multiple-domain framework of clinical, economic, and patient-reported outcomes for evaluating benefits of intervention in atopic dermatitis. , 2007, Journal of drugs in dermatology : JDD.
[96] R. Beavis,et al. Bacterial interference caused by autoinducing peptide variants. , 1997, Science.
[97] O. Schneewind,et al. Vaccine assembly from surface proteins of Staphylococcus aureus , 2006, Proceedings of the National Academy of Sciences.
[98] D. Leung,et al. Antiviral activity of human beta-defensin 3 against vaccinia virus. , 2007, The Journal of allergy and clinical immunology.
[99] R. Damstra,et al. Twice weekly fluticasone propionate added to emollient maintenance treatment to reduce risk of relapse in atopic dermatitis: randomised, double blind, parallel group study , 2003, BMJ : British Medical Journal.
[100] Junguk Park,et al. Infection control by antibody disruption of bacterial quorum sensing signaling. , 2007, Chemistry & biology.
[101] K. Barnes. An update on the genetics of atopic dermatitis: scratching the surface in 2009. , 2010, The Journal of allergy and clinical immunology.
[102] B. Harder,et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. , 2006, The Journal of allergy and clinical immunology.
[103] G. K. Khurana Hershey,et al. Intrinsically defective skin barrier function in children with atopic dermatitis correlates with disease severity. , 2008, The Journal of allergy and clinical immunology.
[104] Scott R. Presnell,et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice , 2004, Nature Immunology.
[105] J. Ring,et al. Silver-Coated Textiles Reduce Staphylococcus aureus Colonization in Patients with Atopic Eczema , 2003, Dermatology.
[106] A. Kennedy,et al. Identification of novel cytolytic peptides as key virulence determinants for community-associated MRSA , 2007, Nature Medicine.
[107] Jonathan Hadgraft,et al. Epidermal barrier dysfunction in atopic dermatitis. , 2009, The Journal of investigative dermatology.
[108] A. Shah,et al. International Study of Asthma and Allergies in Childhood (ISAAC) , 2000, The Journal of the Association of Physicians of India.
[109] D. Leung,et al. Antiviral activity of human β-defensin 3 against vaccinia virus , 2007 .
[110] B. Moza,et al. Neutralization of staphylococcal enterotoxin B by soluble, high-affinity receptor antagonists , 2007, Nature Medicine.
[111] P. Schlievert,et al. Superantigen profile of Staphylococcus aureus isolates from patients with steroid-resistant atopic dermatitis. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[112] U. Wahn,et al. Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. , 2000, The Journal of allergy and clinical immunology.
[113] R. Geha,et al. Exaggerated IL-17 response to epicutaneous sensitization mediates airway inflammation in the absence of IL-4 and IL-13. , 2009, The Journal of allergy and clinical immunology.
[114] S. Hong,et al. Epidemiological Characteristics of Methicillin-Resistant Staphylococcus aureus Isolates from Children with Eczematous Atopic Dermatitis Lesions , 2008, Journal of Clinical Microbiology.
[115] R. Novick. Autoinduction and signal transduction in the regulation of staphylococcal virulence , 2003, Molecular microbiology.
[116] H. Stark,et al. The histamine H4 receptor is functionally expressed on T(H)2 cells. , 2009, The Journal of allergy and clinical immunology.
[117] C. Akdis,et al. Absence of T-regulatory cell expression and function in atopic dermatitis skin. , 2006, The Journal of allergy and clinical immunology.
[118] K. Kaulback,et al. The Socioeconomic Impact of Atopic Dermatitis in the United States: A Systematic Review , 2008, Pediatric dermatology.
[119] K. Bork,et al. Increasing incidence of eczema herpeticum: analysis of seventy-five cases. , 1988, Journal of the American Academy of Dermatology.
[120] R. Gallo,et al. Antimicrobial peptides and the skin immune defense system. , 2008, The Journal of allergy and clinical immunology.
[121] Colin N A Palmer,et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis , 2006, Nature Genetics.